Hims & Hers Health Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Hims & Hers Health, Inc. (HIMS) is a US-based telehealth company that provides direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for treatment in areas such as mental health, dermatology, sexual health, and general wellbeing.
Its platform supports asynchronous and live consultations, with personalised treatment plans and prescriptions delivered directly to patients. The company operates under two consumer brands: Hims (targeted at men) and Hers (targeted at women), offering both subscription-based and one-time purchase options.
Hims & Hers also sells over-the-counter health and personal care products via its website and selected retail partners. Its vertically integrated model combines clinical services, pharmacy operations, and proprietary technology to support scalable, accessible care.
Hims & Hers Health is listed on the New York Stock Exchange (NYSE).